The Liver Disease Panel includes LiverPRO—a certified algorithm developed by the health tech company Evido—requiring only age and routine blood markers for the timely detection of liver fibrosis With ...

Roche has introduced what it says is the first comprehensive panel of certified algorithms to help manage people living with chronic liver disease (CLD). The Liver Disease Panel has been added to the ...

Accurate non-invasive biomarkers to diagnose metabolic dysfunction-associated steatotic liver disease (MASLD)-related fibrosis are urgently needed. This study applies a translational approach to ...

This study investigates the impact of Body Mass Index (BMI) and Waist-to-Hip Ratio (WHR) on Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST) levels, as well as the mediating role of ...

Roche introduces the first comprehensive library of certified healthcare algorithms to support chronic liver disease (CLD) management The Liver Disease Panel includes LiverPRO-a certified algorithm ...

Roche announced the launch of its comprehensive Liver Disease Panel, a suite of certified algorithms designed to help clinicians better identify and manage chronic liver disease (CLD). By bringing ...